302 related articles for article (PubMed ID: 28275862)
1. Risk for life-threatening arrhythmia in newly diagnosed peripartum cardiomyopathy with low ejection fraction: a German multi-centre analysis.
Duncker D; Westenfeld R; Konrad T; Pfeffer T; Correia de Freitas CA; Pfister R; Thomas D; Fürnkranz A; Andrié RP; Napp A; Schmitt J; Karolyi L; Wakili R; Hilfiker-Kleiner D; Bauersachs J; Veltmann C
Clin Res Cardiol; 2017 Aug; 106(8):582-589. PubMed ID: 28275862
[TBL] [Abstract][Full Text] [Related]
2. Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter/defibrillator.
Duncker D; Haghikia A; König T; Hohmann S; Gutleben KJ; Westenfeld R; Oswald H; Klein H; Bauersachs J; Hilfiker-Kleiner D; Veltmann C
Eur J Heart Fail; 2014 Dec; 16(12):1331-6. PubMed ID: 25371320
[TBL] [Abstract][Full Text] [Related]
3. Ventricular arrhythmias in patients with newly diagnosed nonischemic cardiomyopathy: Insights from the PROLONG study.
Duncker D; König T; Hohmann S; Bauersachs J; Veltmann C
Clin Cardiol; 2017 Aug; 40(8):586-590. PubMed ID: 28333373
[TBL] [Abstract][Full Text] [Related]
4. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
Kutyifa V; Moss AJ; Klein H; Biton Y; McNitt S; MacKecknie B; Zareba W; Goldenberg I
Circulation; 2015 Oct; 132(17):1613-9. PubMed ID: 26316618
[TBL] [Abstract][Full Text] [Related]
5. Peripartum cardiomyopathy: predictors of recovery and current state of implantable cardioverter-defibrillator use.
Pillarisetti J; Kondur A; Alani A; Reddy M; Reddy M; Vacek J; Weiner CP; Ellerbeck E; Schreiber T; Lakkireddy D
J Am Coll Cardiol; 2014 Jul; 63(25 Pt A):2831-9. PubMed ID: 24814494
[TBL] [Abstract][Full Text] [Related]
6. Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study.
Duncker D; König T; Hohmann S; Bauersachs J; Veltmann C
J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28096098
[TBL] [Abstract][Full Text] [Related]
7. Wearable cardioverter defibrillator after cardiac surgery: Analysis of real-life data from patients at transient risk of sudden cardiac death.
Elbayomi M; Weyand M; Seitz T; Harig F
Ann Noninvasive Electrocardiol; 2023 Mar; 28(2):e13048. PubMed ID: 36723848
[TBL] [Abstract][Full Text] [Related]
8. The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital.
Sinha AM; Bense J; Hohenforst-Schmidt W
J Interv Card Electrophysiol; 2021 Nov; 62(2):401-407. PubMed ID: 33200285
[TBL] [Abstract][Full Text] [Related]
9. Delayed Improvement of Left Ventricular Function in Newly Diagnosed Heart Failure Depends on Etiology-A PROLONG-II Substudy.
Mueller-Leisse J; Brunn J; Zormpas C; Hohmann S; Hillmann HAK; Eiringhaus J; Bauersachs J; Veltmann C; Duncker D
Sensors (Basel); 2022 Mar; 22(5):. PubMed ID: 35271182
[TBL] [Abstract][Full Text] [Related]
10. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.
Epstein AE; Abraham WT; Bianco NR; Kern KB; Mirro M; Rao SV; Rhee EK; Solomon SD; Szymkiewicz SJ
J Am Coll Cardiol; 2013 Nov; 62(21):2000-2007. PubMed ID: 23916930
[TBL] [Abstract][Full Text] [Related]
11. Wearable cardioverter defibrillator multicentre experience in a large cardiac surgery cohort at transient risk of sudden cardiac death.
Kuehn C; Ruemke S; Rellecke P; Lichtenberg A; Joskowiak D; Hagl C; Hassan M; Leyh RG; Erler S; Garbade J; Eifert S; Grieshaber P; Boening A; Doenst T; Velichkov I; Madej T; Knaut M; Hain A; Burger H
Eur J Cardiothorac Surg; 2022 May; 61(5):1031-1040. PubMed ID: 35174386
[TBL] [Abstract][Full Text] [Related]
12. Sex differences in arrhythmic burden with the wearable cardioverter-defibrillator.
Goldenberg I; Erath JW; Russo AM; Burch AE; Assmus B; Bonderman D; McNitt S; Kutyifa V
Heart Rhythm; 2021 Mar; 18(3):404-410. PubMed ID: 33248269
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of implantable loop recorder and Holter electrocardiographic monitoring for the detection of arrhythmias in patients with peripartum cardiomyopathy.
Hoevelmann J; Sliwa K; Briton O; Ntsekhe M; Chin A; Viljoen C
Clin Res Cardiol; 2023 Mar; 112(3):379-391. PubMed ID: 36131137
[TBL] [Abstract][Full Text] [Related]
14. Experience with the wearable cardioverter-defibrillator in older patients: Results from the Prospective Registry of Patients Using the Wearable Cardioverter-Defibrillator.
Daimee UA; Vermilye K; Moss AJ; Goldenberg I; Klein HU; McNitt S; Zareba W; Kutyifa V
Heart Rhythm; 2018 Sep; 15(9):1379-1386. PubMed ID: 29678779
[TBL] [Abstract][Full Text] [Related]
15. Performance of the entirely subcutaneous ICD in borderline indications.
Willy K; Reinke F; Bögeholz N; Köbe J; Eckardt L; Frommeyer G
Clin Res Cardiol; 2020 Jun; 109(6):694-699. PubMed ID: 31586219
[TBL] [Abstract][Full Text] [Related]
16. Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry.
Veltmann C; Winter S; Duncker D; Jungbauer CG; Wäßnig NK; Geller JC; Erath JW; Goeing O; Perings C; Ulbrich M; Roser M; Husser D; Gansera LS; Soezener K; Malur FM; Block M; Fetsch T; Kutyifa V; Klein HU
Clin Res Cardiol; 2021 Jan; 110(1):102-113. PubMed ID: 32377784
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up in peripartum cardiomyopathy patients with contemporary treatment: low mortality, high cardiac recovery, but significant cardiovascular co-morbidities.
Moulig V; Pfeffer TJ; Ricke-Hoch M; Schlothauer S; Koenig T; Schwab J; Berliner D; Pfister R; Michels G; Haghikia A; Falk CS; Duncker D; Veltmann C; Hilfiker-Kleiner D; Bauersachs J
Eur J Heart Fail; 2019 Dec; 21(12):1534-1542. PubMed ID: 31724271
[TBL] [Abstract][Full Text] [Related]
18. ECG and arrhythmias in peripartum cardiomyopathy.
Duncker D; Pfeffer TJ; Bauersachs J; Veltmann C
Herzschrittmacherther Elektrophysiol; 2021 Jun; 32(2):207-213. PubMed ID: 33791817
[TBL] [Abstract][Full Text] [Related]
19. Utility of the Wearable Cardioverter-Defibrillator in Patients With Newly Diagnosed Cardiomyopathy: A Decade-Long Single-Center Experience.
Singh M; Wang NC; Jain S; Voigt AH; Saba S; Adelstein EC
J Am Coll Cardiol; 2015 Dec; 66(23):2607-2613. PubMed ID: 26670060
[TBL] [Abstract][Full Text] [Related]
20. Absence of left bundle branch block and blood urea nitrogen predict improvement in left ventricular ejection fraction in patients with cardiomyopathy and wearable cardioverter defibrillators.
Mehta NA; Abdulsalam N; Kouides R; Ahmed H; Atif R; Shah A; Taylor S; Chuprun D; Huang D; Rao M
Clin Cardiol; 2020 Mar; 43(3):260-266. PubMed ID: 31860745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
